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Abstract
BACKGROUND—Annual updates on cancer occurrence and trends in the United States are 
provided through collaboration between the American Cancer Society (ACS), the Centers for 
Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North 
American Association of Central Cancer Registries (NAACCR). This year’s report highlights the 
increased cancer risk associated with excess weight (overweight or obesity) and lack of sufficient 
physical activity (<150 minutes of physical activity per week).
METHODS—Data on cancer incidence were obtained from the CDC, NCI, and NAACCR; data 
on cancer deaths were obtained from the CDC’s National Center for Health Statistics. Annual 
percent changes in incidence and death rates (age-standardized to the 2000 US population) for all 
cancers combined and for the leading cancers among men and among women were estimated by 
joinpoint analysis of long-term trends (incidence for 1992–2008 and mortality for 1975–2008) and 
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short-term trends (1999–2008). Information was obtained from national surveys about the 
proportion of US children, adolescents, and adults who are overweight, obese, insufficiently 
physically active, or physically inactive.
RESULTS—Death rates from all cancers combined decreased from 1999 to 2008, continuing a 
decline that began in the early 1990s, among men and among women in most racial and ethnic 
groups. Death rates decreased from 1999 to 2008 for most cancer sites, including the 4 most 
common cancers (lung, colorectum, breast, and prostate). The incidence of prostate and colorectal 
cancers also decreased from 1999 to 2008. Lung cancer incidence declined from 1999 to 2008 
among men and from 2004 to 2008 among women. Breast cancer incidence decreased from 1999 
to 2004 but was stable from 2004 to 2008. Incidence increased for several cancers, including 
pancreas, kidney, and adenocarcinoma of the esophagus, which are associated with excess weight.
CONCLUSIONS—Although improvements are reported in the US cancer burden, excess weight 
and lack of sufficient physical activity contribute to the increased incidence of many cancers, 
adversely affect quality of life for cancer survivors, and may worsen prognosis for several cancers. 
The current report highlights the importance of efforts to promote healthy weight and sufficient 
physical activity in reducing the cancer burden in the United States.
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INTRODUCTION
The Annual Report to the Nation has provided updated cancer incidence and mortality data 
for the United States since the initial report in 1998, which demonstrated the first continuous 
decline in cancer mortality rates since the 1930s.1 In addition, each report has included a 
special section focused on important public health topics, cancer in special populations, or 
cancers of special interest.2–13 This year’s report continues the collaborative effort between 
the American Cancer Society (ACS), the Centers for Disease Control and Prevention 
(CDC), the National Cancer Institute (NCI), and the North American Association of Central 
Cancer Registries (NAACCR). This report provides updated information on incidence and 
mortality trends for all cancers combined, for childhood cancers, and for the top 15 cancers 
for each of 5 major racial and ethnic groups by sex (totaling 17 cancers among men and 18 
cancers among women). This report also highlights several cancers associated with excess 
weight (overweight and obesity) and lack of sufficient physical activity and describes 
temporal and regional patterns of excess weight and insufficient physical activity among US 
children, adolescents, and adults.
MATERIALS AND METHODS
Cancers, Cancer Deaths, and Population Estimates
Population-based data on cancer incidence, including newly diagnosed cases, are based on 
information collected by central cancer registries in the CDC’s National Program of Cancer 
Eheman et al. Page 2
Cancer. Author manuscript; available in PMC 2015 September 28.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Registries (NPCR) and/or the NCI’s Surveillance, Epidemiology, and End Results (SEER) 
Program. These registries, as members of the NAACCR, submit data annually to that 
organization for evaluation and use in this report. Site and histology for incident cancers 
were coded according to the International Classification of Diseases for Oncology (ICD-O) 
edition in use at the time of diagnosis, converted to the Third Edition coding,14 and 
categorized according to SEER site groups.15 Incidence rates were calculated for all sites 
combined, for childhood cancers, and for the top 15 cancers among men and women for 
each of 5 major racial and ethnic groups (white, black, Asian and Pacific Islander [API], 
American Indian/Alaska Native [AI/AN], and Hispanic). Information regarding race and 
Hispanic ethnicity was collected separately. Hispanic ethnicity includes men and women 
from all race categories identified as Hispanic. Rates for AI/ANs were based on cases and 
deaths in counties covered by the Indian Health Service’s Contract Health Service Delivery 
Area, because these rates most accurately reflect the true rates in these populations.10
Incidence data were not available uniformly for every period, geographic area, or racial and 
ethnic group in the United States. Long-term (1992–2008) incidence trends for all racial and 
ethnic groups combined were estimated using data from the SEER 13 registries, which 
provide coverage of 14% of the US population.16 Beginning in 1995, after the advent of the 
NPCR, coverage of the US population increased dramatically. Consequently, 5-year (2004–
2008) average annual incidence rates and short-term (1999–2008) incidence trends for all 
racial and ethnic groups combined and for each of 5 major racial and ethnic populations 
were calculated using data from NPCR and SEER registries. For the period from 2004 to 
2008, 48 registries (covering 96% of the US population) met the NAACCR data quality 
criteria, and for the period from 1999 to 2008, 41 registries (covering 86% of the US 
population) met these criteria.
Cause of death was based on death certificate information reported to state vital statistics 
offices and compiled into a national file through the CDC National Center for Health 
Statistics’ National Vital Statistics System.17 To maximize comparability among 
International Classification of Diseases (ICD) and ICD-O versions, cause of death was 
categorized according to SEER anatomic site groups.15 The underlying causes of death were 
selected according to the version of the ICD codes and selection rules in use at the time of 
death (ICD-6 to ICD-10). Death rates were calculated for all sites combined, for childhood 
cancers, and for the top 15 cancers for each of 5 major racial and ethnic groups by sex. We 
examined long-term (1975–2008) mortality trends for all racial and ethnic groups combined 
and 5-year (2004–2008) average annual mortality rates and short-term (1999–2008) 
mortality trends for all racial and ethnic groups combined and for each of 5 major racial and 
ethnic groups.
Population estimates used in the SEER*Stat software (available at: http://seer.cancer.gov/
seerstat [accessed January 27, 2012]) were a modified version of the annual time series of 
July 1 county population estimates by age, sex, race, and ethnicity produced by the US 
Census Bureau.16 Modifications incorporated bridged, single-race estimates that were 
derived from multiple-race categories in the 2000 Census.18 For most states, population 
estimates as of July 1 of each year were used to calculate annual incidence rates, because it 
is presumed that these estimates reflect the average population of a defined geographic area 
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for a calendar year. However, certain county population estimates were adjusted to account 
for populations displaced along the Gulf Coast of Louisiana, Alabama, Mississippi, and 
Texas in fall 2005 by hurricanes Katrina and Rita.16 National total population estimates 
were not affected by these adjustments. Other specific modifications included using 
additional local information to estimate the native Hawaiian population accurately and to 
derive population estimates for a newly created county in Colorado.16 These modified 
county-level population estimates, summed to the state and national levels, were used as 
denominators in rate calculations.16
Statistical Analyses of Incidence and Mortality Trends
Average annual incidence rates per 100,000 persons were age-adjusted to the 2000 US 
standard population by using the direct method.19 Corresponding 95% confidence intervals 
were calculated as modified gamma intervals.20 For stability and reliability, rates were not 
reported if the numerator included fewer than 16 observations.
Trends in age-standardized cancer incidence and death rates were analyzed using joinpoint 
regression, which involves fitting a series of joined straight lines on a logarithmic scale to 
the trends in the annual age-standardized rates (available at: http://www.srab.cancer.gov/
join-point [accessed January 27, 2012]).21 Up to 3 joinpoints were allowed in models for the 
period from 1992 to 2008 (Table 1), up to 5 joinpoints were allowed in models for the 
period from 1975 to 2008 (Table 2), and up to 2 joinpoints were allowed in models for the 
period from 1999 to 2008 (Tables 3 and 4). The resulting trends of various periods were 
described by the slope of the line segment or the annual percent change (APC). The average 
APC (AAPC) was estimated as a geometric weighted average of the APCs, with the weights 
equal to the length of each line segment during the prespecified, fixed interval (available at: 
http://srab.cancer.gov/joinpoint/aapc.html [accessed January 27, 2012]).22 Long-term 
incidence trends were calculated using both observed and delay-adjusted SEER 13 data 
(Table 1); descriptions of these trends were based on the delay-adjusted data, except when 
noted. Delay adjustment is a statistical method that corrects for unreported (delayed) or 
updated cases and mostly affects cancers diagnosed in recent years and cancers diagnosed in 
nonhospital settings, eg, melanoma or leukemia.23 The t test was used to test whether the 
APC was statistically different from zero, and the Z test was used to test whether the AAPC 
was statistically different from zero; all statistical tests were 2-sided. In describing trends, 
the terms increase or decrease were used when the slope (APC or AAPC) of the trend was 
statistically significant (P < .05). For nonstatistically significant trends, terms such as stable, 
nonsignificant increase, and nonsignificant decrease were used.
Excess Weight and Lack of Sufficient Physical Activity and Associated Cancers
A rigorous review of more than 7000 studies on the relation between nutrition, physical 
activity, excess weight, and cancer risk concluded that there is convincing evidence of an 
association between excess weight and increased risk of several cancers, including 
adenocarcinoma of the esophagus, colon and rectum cancer, kidney cancer, pancreas cancer, 
postmenopausal female breast cancer, and endometrial cancer.24 In this report, incidence 
rates are presented for these 6 cancers. Postmenopausal breast cancer was approximated by 
estimating rates among women aged ≥50 years. Because most cancers (95%) of the corpus 
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uterus are diagnosed in the endometrium, uterine cancer rates were used to describe 
endometrial cancer. Incidence rates are also presented for 3 cancers for which the review 
concluded that the evidence of an association between physical inactivity and increased risk 
of cancer is considered convincing (colon cancer) or probable (postmenopausal breast and 
endometrial cancers).24
The prevalence of overweight and obesity among US children, adolescents, and adults was 
obtained from published estimates from the National Health and Nutrition Examination 
Survey (NHANES).25–29 In this report, we used body mass index (BMI), which is calculated 
as weight in kilograms divided by height in meters squared, to define healthy weight, 
overweight, and obesity.30 In adults, BMI in the range from 18.5 to 24.9 kg/m2 is considered 
healthy weight, BMI in the range from 25.0 to 29.9 kg/m2 is considered overweight, and 
BMI ≥30 kg/m2 is considered obese.25 In children and adolescents, the definitions of 
overweight and obese are based on the 2000 CDC BMI-for-age-and-sex growth charts; BMI 
in the range from ≥85th percentile to <95th percentile is considered overweight, whereas 
BMI ≥95th percentile is considered obese.26 In this report, the definition of excess weight 
includes overweight and obese.
The proportion of US youth participating in physical activity was obtained from published 
estimates from the Youth Risk Behavior Surveillance System (YRBSS).31 In this report, 
physical activity levels were based on Healthy People 2020 objectives32 and were defined as 
youth doing any kind of physical activity that increased their heart rate and made them 
breathe hard some of the time for a total of at least 60 minutes per day on 7 days (active), 1 
to 6 days (insufficiently active), or 0 days (inactive) during the 7 days before the survey. The 
proportion of US adults participating in physical activity was obtained from the National 
Health Interview Survey (NHIS).33 In this report, physical activity levels (during leisure 
time) among adults were based on recent guidelines34 and were defined as engaging in at 
least 150 minutes of moderate-intensity aerobic activity, at least 75 minutes of vigorous-
intensity aerobic activity, or an equivalent combination of moderate-intensity and vigorous-
intensity physical activity per week (active); some aerobic activity but not enough to meet 
the active definition (insufficiently active); or no moderate-intensity or vigorous-intensity 
aerobic activity for at least 10 minutes at a time (inactive). State-specific estimates of the 
prevalence of obesity and physical inactivity were obtained from the YRBSS31 for US youth 
and from the Behavioral Risk Factor Surveillance System(BRFSS) for US adults.35,36
Published estimates of relative risk were obtained from recent comprehensive meta-analyses 
of the association between excess weight and the risk of adenocarcinoma of the esophagus24 
and cancers of the colon and rectum,37 kidney,24 pancreas,24 female breast 
(postmenopausal),38 and endometrium.39 These estimates were given as the risk associated 
with a specified unit change in BMI. Assuming a linear association between BMI and cancer 
risk, we calculated estimates for the risk associated with overweight and obese. Published 
estimates of relative risk were obtained from recent comprehensive meta-analyses of the 
association between physical activity and risk of cancers of the colon,40 female breast 
(postmenopausal),41 and endometrium.42 These estimates originally were presented as the 
risk of the most active relative to the least active; we calculated the inverse to present the 
risk of the least active relative to the most active.
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RESULTS
Long-Term (1992–2008) Cancer Incidence Trends for All Racial and Ethnic Groups 
Combined
Trend analysis based on SEER 13 data indicated that overall delay-adjusted cancer 
incidence in all racial and ethnic groups and sexes combined was stable from 1999 to 2008 
(Table 1). Among men, overall cancer incidence decreased on average by 0.6% annually 
from 1994 to 2008. Overall cancer incidence among women decreased 0.5% annually from 
1998 to 2006, but rates did not change from 2006 to 2008. Overall cancer incidence among 
children ages 0 to 14 years increased 0.5% per year and, among children ages 0 to 19 years, 
incidence increased 0.6% per year from 1999 to 2008, continuing trends from 1992. Among 
men, incidence rates for 5 of the 17 most common cancers decreased from 1999 to 2008: 
prostate, lung and bronchus (lung), colon and rectum (colorectal), stomach, and larynx. In 
contrast, rates among men increased from 1999 to 2008 for 7 cancers: kidney and renal 
pelvis (kidney), pancreas, liver and intrahepatic bile duct (liver), thyroid, melanoma of the 
skin (melanoma), leukemia, and myeloma. Among women, incidence rates decreased from 
1999 to 2008 for 6 of the 18 most common cancers: lung, colorectal, urinary bladder 
(bladder), cervix uteri (cervix), oral cavity and pharynx (oral cavity), and stomach. 
Incidence rates among women increased from 1999 to 2008 for 6 cancers: thyroid, 
melanoma, kidney, pancreas, leukemia, and liver. Incidence rates were unchanged from 
1999 to 2008 for all other cancers.
Long-Term (1975–2008) Cancer Mortality Trends for All Racial and Ethnic Groups 
Combined
Overall cancer death rates have been declining among children since the 1970s and among 
adults since the 1990s (Table 2). Trends in death rates for the most recent 10-year period 
(1999–2008) show an average 1.7% decrease per year among men and an average 1.3% 
decrease per year among women as well as among children ages 0 to 19 years. Death rates 
decreased 1.5% per year among children ages 0 to 14 years. Death rates for 11 of the 17 
most common cancers among men and for 14 of the 18 most common cancers among 
women (lung, colon and rectum, kidney, brain, stomach, oral cavity, leukemia, non-Hodgkin 
lymphoma, and myeloma among both men and women; prostate and larynx among men; and 
breast, ovary, urinary bladder, esophagus, and gallbladder among women) decreased during 
the most recent 10-year (1999–2008) and 5-year (2004–2008) periods. During the same 
periods, death rates increased for pancreatic cancer among both men and women, for liver 
cancer and melanoma of the skin among men, and for corpus uterus (uterine) cancer among 
women. After decades of decline, cervical cancer death rates changed little in the most 
recent period.
Cancer Incidence Rates (2004–2008) and Short-Term (1999–2008) Trends by Race and 
Ethnicity
Five-year (2004–2008) average annual incidence rates and short-term (1999–2008) trends 
were based on combined data from SEER and NPCR registries submitted to the NAACCR 
(Table 3). These data were not adjusted for delayed reporting. Cancer incidence rates 
decreased from 1999 to 2008 among both men and women of all racial and ethnic groups 
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combined, although the decrease was not statistically significant among AI/AN men and 
women combined and among black, API, and AI/AN women. Among children (ages 0–19 
years), cancer incidence rates increased in all racial and ethnic groups combined, although 
this increase was not observed among white, API, or AI/AN children. Prostate cancer 
incidence rates decreased in each racial and ethnic group. For all racial and ethnic groups 
combined, female breast cancer incidence rates were stable from 2004 to 2008. Among men, 
lung cancer incidence rates decreased from 1999 to 2008 in all racial and ethnic groups, but 
this decrease was not statistically significant among AI/AN men. Although lung cancer 
incidence rates among women in all racial and ethnic groups combined were stable over the 
10-year period, rates decreased significantly in the most recent 5 years. Colorectal cancer 
incidence rates decreased among both men and women in all racial and ethnic groups but did 
not decrease significantly among AI/AN men or women. Uterine cancer incidence rates 
increased among black, API, and Hispanic women.
The incidence rate for all cancers combined was 33% higher among men than among 
women (Table 3). Black men had the highest cancer incidence rate from 2004 to 2008 of any 
racial and ethnic group, with overall rates 15% higher than those of white men and nearly 
double the rates of API men. The top 3 most commonly diagnosed cancers among men in 
each racial and ethnic group, except Hispanic men, were, in rank order, prostate, lung, and 
colorectal cancer; among Hispanic men, the incidence rate of colorectal cancer was slightly 
higher than the incidence of lung cancer. Among women, overall cancer incidence rates 
were highest among non-Hispanic and white women. Breast cancer was the most commonly 
diagnosed cancer among women in each racial and ethnic group. Incident lung and 
colorectal cancers ranked second and third, respectively, among women of all racial and 
ethnic groups combined and for white, black, and AI/AN women. However, these rankings 
were reversed among API and Hispanic women. Incident uterine cancer ranked fourth for all 
women except API women, in whom the fourth most common cancer was thyroid. Thyroid 
cancer is now the fifth most common incident cancer among women of all racial and ethnic 
groups combined, with the highest rates observed among white and API women. Beyond the 
top 3 most commonly diagnosed cancers among men and the top 4 most commonly 
diagnosed cancers among women, cancer rankings varied considerably by race and 
ethnicity.
Current Cancer Death Rates (2004–2008) and Short-Term (1999–2008) Trends by Race and 
Ethnicity
Overall cancer death rates declined from 1999 to 2008 among men, women, and children in 
all racial and ethnic groups combined (Table 4). Overall cancer death rates declined in each 
racial and ethnic group except AI/AN men, women, and children, among whom declines 
were not significant. Similarly, among men, death rates for the most common cancers (lung, 
colorectal, and prostate) decreased in all racial and ethnic groups except among AI/AN men, 
in whom the rates remained unchanged. Among women, death rates for breast and colorectal 
cancers decreased among white, black, and Hispanic women; nonsignificant declines were 
observed for breast and colorectal cancer among API women and for breast cancer among 
AI/AN women. Lung cancer death rates decreased from 2004 to 2008 among women of all 
racial and ethnic groups combined. Death rates increased for liver cancer among white, 
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black, and Hispanic men and white women, for pancreas cancer among white men and 
women, and for melanoma among white men.
Special Section: Excess Weight, Lack of Sufficient Physical Activity, and Associated 
Cancers
From 2007 to 2008, one-third of US children and adolescents were considered overweight or 
obese based on measured weight and height data from NHANES (Table 5). The prevalence 
of obesity was greater among children ages 6 to 19 years than among those ages 2 to 5 years. 
In analyses by racial and ethnic group, the prevalence of obesity was highest among 
Hispanic boys and non-Hispanic black girls. From 2005 to 2008, children and adolescents 
who lived in households headed by those with a college degree had the lowest prevalence of 
obesity.
From 2007 to 2008 two-thirds of US adults were considered overweight or obese based on 
measured weight and height data from NHANES (Table 5). The prevalence of obesity was 
highest among men aged ≥60 years and among women aged 40 to 59 years. In analyses by 
racial and ethnic group, the prevalence of obesity was highest among non-Hispanic black 
men and women and among Hispanic women. From 2005 to 2008, adults with a college 
degree had the lowest prevalence of obesity.
Data from NHANES indicate that the prevalence of obesity among US adults increased 
slowly from the 1960s to the 1980s then increased sharply until 1999/2000 (Fig. 1). From 
1999 to 2008, the prevalence of obesity remained stable in women and increased slightly in 
men (most of the increase occurred early in this period).43
On the basis of self-reported weight and height data from the BRFSS, the prevalence of 
obesity among US adults increased in all states from 1995 to 2010 (Fig. 2). Rates were 
consistently higher among Southern and Midwestern states.
On the basis of data from YRBSS, in 2009, 75% of US high school boys and 89% of US 
high school girls did not engage in recommended levels of physical activity; 17% of boys 
and 30% of girls were considered physically inactive (Table 6). The prevalence of physical 
inactivity increased with grade level. In analyses by racial and ethnic group, the prevalence 
of physical inactivity was highest among non-Hispanic black boys and girls.
On the basis of data from the NHIS, in 2008, 53% of US men and 60% of US women did 
not engage in recommended levels of aerobic physical activity; more than one-third were 
considered physically inactive (Table 6). The prevalence of aerobic physical inactivity 
increased with age and was highest among Hispanic men and non-Hispanic black women. 
Adults with a college degree had the lowest prevalence of aerobic physical inactivity.
On the basis of data from the BRFSS, from 2000 to 2010, prevalence rates of aerobic 
physical inactivity among adults stayed the same or decreased in most states and were 
lowest for states in the West and highest for states in the South (Fig. 3).
Incidence rates and trends for cancers associated with excess weight and lack of sufficient 
physical activity are presented in Table 7 (long-term trends for all racial and ethnic groups 
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combined) and Table 8 (5-year rates and short-term trends by racial and ethnic group). 
Although colorectal cancer incidence decreased from 1999 to 2008, rates of postmenopausal 
breast cancer stabilized from 2005 to 2008 after declining from 1999 to 2005, and incidence 
of some cancers increased (Table 7). Kidney cancer incidence increased from 1999 to 2008 
approximately 2.9% per year among men (accelerating to 4.1% from 2004 to 2008) and 
3.3% among women (Table 7); increases were evident in all racial and ethnic groups (Table 
8). Pancreas cancer increased approximately 1.2% per year from 1999 to 2008 (accelerating 
slightly from 2004 to 2008) among both men and women (Table 7), although this increase 
was confined to whites (Table 8). A significant increase from 1999 to 2008 in uterine cancer 
was observed among black, API, and Hispanic women; a nonsignificant increase was 
observed among white and AI/AN women (Table 8). From 1992 to 2008, adenocarcinoma 
of the esophagus increased 2.6% per year among men and 3.3% per year among women 
(Table 7); these increases were restricted to white and Hispanic men and white women 
(Table 8). State-specific 5-year (2004–2008) average annual incidence rates for cancers 
associated with excess weight and lack of sufficient physical activity are presented in Table 
9.
On the basis of results from published comprehensive meta-analyses of BMI, each 5-kg/m2 
increase in BMI is associated with 30% to 60% increased risk of endometrial cancer,39 
adenocarcinoma of the esophagus,24 and kidney cancer24 and with a 13% to 18% increased 
risk of colorectal cancer,37 pancreatic cancer,24 and postmenopausal breast cancer38 (Table 
10). On the basis of results from published comprehensive meta-analyses of physical 
activity, lack of sufficient physical activity has been associated with a 30% to 40% increased 
risk of colon cancer,40 postmenopausal breast cancer,41 and endometrial cancer42 (Table 
10).
DISCUSSION
This Annual Report to the Nation documents continued declines in mortality from all 
cancers combined. These declines indicate progress across the cancer continuum, including 
primary prevention, which involves education about risk factors and promotion of healthy 
behaviors, increased screening and early detection, and improved treatment. Differences by 
racial and ethnic group suggest differences in risk behaviors as well as access to and use of 
screening and treatment.44–48
Lung cancer incidence and mortality continue to decline among both men and women, 
reflecting the success of tobacco-control strategies to prevent initiation, accelerate declines 
in consumption, and promote cessation.11,45,49 Although a decline in lung cancer has been 
observed among men for years, the beginning of a decline was first documented among 
women in last year’s report13 and is driven largely by declines in states with strong, long-
running, comprehensive tobacco-control programs.49
Prostate cancer incidence has fluctuated through the years, with a large peak in 1992 
corresponding to an increase in prostate-specific antigen (PSA) testing,50 but has decreased 
significantly, although not uniformly, since 1992.15 Prostate cancer death rates also have 
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decreased substantially over time. The contribution of PSA testing to this decline and the 
risks and benefits for individual men remain uncertain.50
Trends in breast cancer incidence over time reflect long-term changes in reproductive and 
other risk factors, introduction and increased prevalence of mammography screening, and 
use of hormones among postmenopausal women.51 After sharp declines in breast cancer 
incidence among women from 2002 to 2003 associated with reduced use of hormone 
replacement therapy,13,52 breast cancer incidence rates have stabilized since 2004. The 
prevalence of mammography screening among women aged ≥40 years that peaked at 70% in 
2000 has since plateaued,53 which is consistent with the stabilization in breast cancer 
incidence rates.
Colorectal cancer incidence and death rates continue to decline, most likely attributable to 
significant improvements in the use of colorectal cancer screening, which can prevent cancer 
development through removal of precancerous adenomatous polyps.12,54 Still, more than 
one-third of US adults do not receive recommended colorectal screening.44,55 Innovative 
systems-level changes are needed to make screening available, affordable, and routine for all 
adults ages 50 to years and would prevent even more colorectal cancer cases and deaths.44
This report highlights cancers associated with excess weight and lack of sufficient physical 
activity. For more than 30 years, excess weight, insufficient physical activity, and an 
unhealthy diet have been considered second only to tobacco as preventable causes of disease 
and death in the United States.56 However since the 1960s, tobacco use has declined by one-
third, whereas obesity rates have doubled, significantly impacting the relative contributions 
of these factors to the disease burden.57–59 Excess weight and lack of sufficient physical 
activity have been linked to increased risk of cardiovascular disease, hypertension, diabetes, 
and arthritis as well as many cancers.60,61 Specifically, excess weight has been convincingly 
associated with increased risk of adenocarcinoma of the esophagus, colon and rectal cancer, 
pancreas cancer, kidney cancer, and, in women, endometrial and postmenopausal breast 
cancers.24,37–39 Considerable evidence suggests that excess weight also may be associated 
with increased risk of other cancers, including gallbladder, liver, thyroid, and hematopoietic 
cancers.24 Lack of sufficient physical activity is associated with increased risk of colon, 
endometrial, and postmenopausal breast cancers and also may be associated with 
premenopausal breast cancer.24,34,40–42,62 This report indicates that, over the past 10 years, 
although incidence rates have decreased for colorectal cancer, the rates have stabilized for 
postmenopausal breast cancer and have increased for several of these cancers, including 
pancreas, kidney, liver, and thyroid cancers and adenocarcinoma of the esophagus. 
Endometrial cancer incidence is increasing among black, API, and Hispanic women. 
Although all of these cancers are influenced by multiple factors, the high prevalence of 
excess weight and insufficient physical activity63 likely contributed to these observed 
increases and to the lack of decline in breast cancer.64
Excess weight and lack of sufficient physical activity also may adversely affect cancer 
prognosis and quality of life among cancer survivors. Research indicates that excess weight 
is associated with poorer survival among patients with breast cancer65–67 and colorectal 
cancer.68–70 Recent research suggests that physical activity after diagnosis of breast or colon 
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cancer is associated with reduced all-cause and cancer-specific mortality (R. Ballard-
Barbash, personal communication). For prostate cancer, obesity is associated with mortality 
and incidence of late-stage disease but not with incidence of early-stage disease.71 Screening 
rates for breast and cervical cancers are lower among women who are obese, which may 
lead to diagnosis at later stage of disease.72,73
Although trends in the prevalence of excess weight and physical inactivity in the United 
States seem to be stabilizing or improving, current levels, particularly the unprecedented 
high levels of obesity among young individuals,74,75 are concerning and can impact future 
disease rates. Unhealthy behaviors among young individuals may lead to unhealthy 
behaviors in adulthood76,77 as well as adverse health profiles78–80 and an increased risk of 
cancer later in life.77,81–83 Continued progress in reducing cancer incidence and mortality 
will be difficult without success in promoting healthy weight and physical activity, 
particularly among youth.24,80,81
The International Agency for Research on Cancer concluded that from one-quarter to one-
third of common cancers in industrialized nations were caused by the joint effect of excess 
weight and lack of sufficient physical activity.84 The World Cancer Research Fund/
American Institute for Cancer Research concluded that approximately one-third of common 
cancers in the United States could be prevented by following healthy patterns of physical 
activity and diet, including maintaining a healthy weight.85 These estimates of attributable 
risk are based, in part, on the cancer sites considered, the size of the relative risk used, the 
definitions of physical activity and excess weight, and the prevalence of these risk factors.86 
Although most estimates of attributable risk are similar, some are higher or 
lower.30,62,64,87,88 Despite some differences in the magnitude of the estimates, researchers 
agree that excess weight and lack of sufficient physical activity are important, avoidable 
causes of cancer in the United States and other industrialized nations. Maintaining a healthy 
weight throughout life may be among the most important ways to prevent cancer, 
particularly for individuals who do not smoke. Eating a healthy diet and engaging in 
sufficient physical activity protect against cancer directly, and indirectly by protecting 
against weight gain. These healthy lifestyle behaviors also prevent diseases, such as 
cardiovascular disease and diabetes.60,61,89
Given the very broad influences of excess weight and physical activity on human biology, 
many mechanisms have been considered and examined to explain the observed associations 
between cancer and excess weight and physical inactivity. These mechanisms are complex, 
interrelated, and not completely understood. It has been demonstrated that excess weight and 
physical activity affect the synthesis and metabolism of sex hormones, insulin and related 
growth factors, immune response, and oxidative stress.30,34,62,90–92 For example, 
postmenopausal obesity is related to higher exposures to free estrogens and androgens,93 
and extensive evidence on reproductive epidemiologic risk factors supports a strong role for 
steroid hormones in the etiology of breast, ovarian, and endometrial cancers.30 Excess 
weight and physical inactivity also raise levels of circulating insulin; and chronic 
hyperinsulinemia is associated with the pathogenesis of several cancers related to excess 
weight, including colorectal, breast, pancreatic, and endometrial cancers.94–96 Excess weight 
also may influence the risk of cancer through effects on tumor growth regulators, including 
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mammalian target of rapamycin (mTOR) and 5′ adenosine monophosphate (AMP)-kinase, 
and adipokines, including adiponectin and leptin.30,90,91,97 Moreover, a large and growing 
body of in vitro and animal model studies indicates that physiologic factors linked to excess 
weight and physical inactivity may play a role in cancer etiology by influencing cell growth, 
differentiation, and apoptosis as well as tissue invasion and angiogenesis.97 Research is 
beginning to examine the role of genetics interacting with the exposures of excess weight 
and physical inactivity and cancer outcomes.98 Some research suggests that physical activity 
may influence cell cycle changes differently than calorie restriction.92,99 Emerging research 
indicates that, independent of physical activity, the amount of time spent in sedentary 
behaviors, such as sitting, may adversely affect health outcomes, including cancer.100–102
Fundamentally, excess weight is caused by an energy imbalance in which energy intake 
exceeds energy expended.74,103 Excess of calories and lack of physical activity each 
contribute to excess weight.84 In addition, evidence suggests that sustained breastfeeding 
may help protect infants and young children from becoming overweight or obese.85,104 
Although seemingly simple, the causes of the high rates of excess weight and insufficient 
physical activity in the US today are complex and include individual characteristics as well 
as societal and environmental factors.63,103,105 These include changes over the last few 
decades, such as low rates and short duration of breastfeeding; the increased availability of 
inexpensive, energy-dense food; larger food portion sizes; increased consumption of sugar-
sweetened beverages; a car-dominated society; widening distances between home and work 
or shopping; and a trend toward more sedentary office jobs rather than physically 
demanding jobs.105–107
Recognizing the inter-relationships between individual, societal and environmental factors 
in promoting lifelong health and preventing disease, the National Prevention Strategy has 
identified 4 strategic directions, including healthy communities, clinical and community 
preventive services, an empowered populace, and health equity, as well as 7 targeted 
priorities.108 Two of these priorities address healthy eating and active living as well as 
issues related to personal, social, economic, and environmental factors that influence these 
health behaviors. To improve healthy eating, the National Prevention Strategy recommends 
increasing access to healthy and affordable foods in communities, implementing 
organizational and programmatic nutrition standards and policies, improving nutritional 
quality of the food supply, helping individuals recognize and make healthy food and 
beverage choices, supporting policies and programs to promote breastfeeding, and 
enhancing food safety. To encourage physical activity, the National Prevention Strategy 
recommends encouraging community design and development that supports physical 
activity; promoting and strengthening school and early learning policies and programs that 
increase physical activity; facilitating access to safe, accessible, and affordable places for 
physical activity; supporting workplace policies and programs that increase physical 
activity; and assessing physical activity levels and providing education, counseling, and 
referrals.
To monitor progress and identify opportunities for improvement, the CDC has published a 
series of reports to provide state-specific information on current behavioral indicators as 
well as indicators of policy and environmental supports for fruits and vegetables,109 physical 
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activity,110 children’s food environment,111 and breastfeeding support.112 Some of these 
state supports are highlighted in Table 11. These include strategies to promote and reinforce 
healthy behaviors by requiring physical education and recess in schools; state-level policies 
to support full-time personnel to develop, implement, monitor, and maintain physical 
activity interventions and programs; strategies to improve the food environment by 
increasing access to healthy foods; food policy councils that can support improved food 
environments for healthy eating through consideration of the local food system; and state 
regulations to support breastfeeding in childcare centers. Investing in policies to support 
public health has been associated with decreases in mortality, including cancer.113
The economic burden caused by excess weight and physical inactivity is substantial. 
According to recent data, per capita medical spending in the United States in 2008 for an 
obese individual was 42% higher ($1429) per year compared with someone of normal 
weight, resulting in a national burden of $147 billion: approximately 9.1% of all medical 
spending.114 In addition to medical costs, indirect costs of obesity include decreased years 
of disability-free life, increased mortality before retirement, earlier retirement, higher 
disability pensions, increased work absenteeism, and reduced productivity.115 Physical 
inactivity, independent of obesity, results in excessive direct medical costs,116,117 
accounting for 2.4% of total US health care expenditures in 1995.118
Limitations
High-quality cancer surveillance in the United States now covers the entire population for 
mortality and 96% of the population for incidence; however, certain limitations in data 
sources, data collection, and analyses may have influenced the findings of this report. First, 
state and national population estimates are provided annually by the Census Bureau to 
estimate postcensal populations. Differences between the numerator (incidence data) and 
denominator (US Census population data) can occur in the designation of characteristics like 
age, race, ethnicity, and place of residency. Postcensal population estimates based on 
numbers updated by birth and death data are more subject to error than estimates based on 
the actual Census count; errors in these estimates may increase as time passes from the 
original recording of Census data. In addition, the NCI modified these Census estimates to 
account for changes in 2005 county-level populations because of displacement of 
individuals after Hurricanes Katrina and Rita in the most affected counties of Louisiana, 
Mississippi, Alabama, and Texas.
Second, as routinely noted in previous Annual Reports to the Nation,1–13 the broad racial 
and ethnic groups categorized for our analyses may mask variations in the cancer burden by 
country of origin or by other unique characteristics of high-risk or low-risk populations. 
Also, cancer rates for racial and ethnic groups may be affected by difficulties in ascertaining 
race and ethnicity information from medical records, death certificates, and Census 
reports.119
Third, the analysis of trends should be carefully interpreted for several reasons. Changes in 
incidence may result from changes in the prevalence of risk factors, the introduction or 
increased use of screening or diagnostic techniques, or a combination of these. The AAPC 
was used as a summary measure to average trends over a 5-year or 10-year period using 
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joinpoint regression; joinpoint models identify recent changes in the magnitude and 
direction of trends but may give the impression of a continuous increase or decrease over 
time when this is not the case. Furthermore, delayed case reporting may affect incidence 
trends if the most recent joinpoint segments overestimate recent declines or underestimate 
recent increases; methods to adjust for delayed reporting23 were used in our report only in 
the analysis of SEER 13 data. The largest effects of adjusting for delayed reporting are 
observed for cancers diagnosed in non-hospital settings, such as melanoma and leukemia. 
This report presents trends based both on data from the SEER 13 registries and on combined 
data from the NAACCR, which includes SEER and NPCR registries. Both data sets have 
strengths and limitations and provide valuable insight into cancer trends in the United States. 
Longer-term trends can be examined using the SEER 13 registries, and these data also have 
been delay adjusted. However, combined data from the SEER and NPCR registries cover 
96% of the US population and may better capture geographic and population differences in 
risk factors and incidence.
Fourth, US Department of Veterans Affairs (VA) hospitals traditionally are a critical source 
of data for cancers diagnosed among veterans, who represent approximately 3% to 8% of 
cancer diagnoses among men. A 2007 policy change regarding the transfer of VA cancer 
data to state central cancer registries has resulted in incomplete reporting of VA hospital 
cases in some, but not all, state registries beginning in the third quarter of the 2004 diagnosis 
year through the current period. Consequently, it is believed that cancer incidence rates 
among men from 2005 to 2008 are underestimated by 0.8% to 1% for all cancers combined 
based on an analysis of data from the SEER 9 registries. The level of underreporting varied 
from 0.2% to 7% according to cancer site, race, and age group.15,120 With the enactment of 
special data-sharing agreements with the VA, progress in collecting data from VA hospitals 
has been made in many states, and this will result in more complete and accurate national 
cancer incidence estimates.
Fifth, state-specific estimates of the prevalence of obesity from the BRFSS likely were 
underestimated because of bias of self-reported weight and height. Although self-reported 
BMI is highly correlated with measured BMI (r > 0.9),121 it often is underestimated; 
because, typically, height is over reported, and weight is under reported, particularly by 
women.122–126 Furthermore, the sensitivity of self-reported data to correctly classify obesity 
was 74% in the New York BRFSS.126 Low sensitivity of self-reported data to correctly 
classify obesity may account for the lower prevalence of obesity estimated from the BRFSS, 
which uses self-reported data, compared with the NHANES, which uses measured data.
Future Directions
The continued declines in cancer death rates for all sites combined and for the leading 
cancer sites among men and women overall and in nearly all racial and ethnic groups 
indicate progress in cancer prevention and control. These decreases are largely a result of 
tobacco prevention and control efforts, screening and early detection of some cancers, and 
improvements in treatment for many cancers.127 Although incidence is decreasing for many 
cancer sites, incidence of other cancers is increasing, including several associated with 
excess body weight.
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Risk factors like tobacco use, excess alcohol consumption, poor diet, excess body weight, 
and physical inactivity contribute to the burden of many cancers.24,128 It is encouraging to 
note that many of these risk factors are modifiable. Reductions in these risk factors over 
time should be reflected in reductions in cancer incidence. For example, declines in lung 
cancer incidence parallel declines in smoking.11,49 Achieving and sustaining healthy 
lifestyle behaviors are essential to reducing the burden of cancer.
The increased cancer risk associated with excess weight and lack of sufficient physical 
activity has been the focus of this report. The US Dietary and Physical Activity Guidelines 
advise individuals in the general population to prevent and/or reduce overweight and obesity 
through improved eating and physical activity behaviors129 and to engage in sufficient 
aerobic and muscle-strengthening activity each week (with sufficient defined for adults as at 
least 150 minutes of moderate-intensity activity [or 75 minutes of vigorous-intensity activity 
or an equivalent combination of both] and muscle-strengthening activities at least 2 days 
each week involving all major muscle groups).34 These guidelines are consistent with those 
for cancer prevention recently updated by the ACS, which recommend that, throughout life, 
individuals should be as lean as possible without being underweight and that adults should 
engage in at least 150 minutes of moderate-intensity activity or 75 minutes of vigorous-
intensity activity each week or an equivalent combination of both.130 The World Cancer 
Research Fund, together with the American Institute for Cancer Research, similarly 
recommends that individuals can reduce their risk of cancer by being as lean as possible 
within the normal body weight range and by staying physically active (at least 30 minutes 
every day) as part of everyday life.24 Recommendations for a healthy diet include 
maintaining appropriate calorie balance throughout life, consuming nutrient-dense foods and 
beverages, increasing the intake of colorful fruits and vegetables, and limiting the intake of 
refined grains, added sugars, cholesterol, saturated fats, trans fats, and sodium (salt).129,130
However, maintaining a healthy weight and engaging in sufficient physical activity cannot 
be promoted solely at the level of the individual. Supporting recommended healthy lifestyle 
behaviors will require concerted actions from individuals; communities; the media; federal, 
state, and local governments; food industries; international agencies; and sectors beyond 
what is usually considered public health, such as transportation and agriculture.84,89,131–134 
Policy and environmental changes can help make healthy choices more accessible, available, 
and affordable.
Geographically specific information that can be linked across the individual, social, and 
physical environments is recognized increasingly as a key element in the framework for 
cancer surveillance.135 For example, enhancing data resources for monitoring and evaluating 
progress in diet, physical activity, and weight is a major focus of the National Collaboration 
of Childhood Obesity Research (NCCOR). The NCCOR, a collaborative effort with the 
CDC, the National Institutes of Health, the US Department of Agriculture, and the Robert 
Wood Johnson Foundation, is focused on policy and environmental research relevant to 
obesity prevention for children. One product of this initiative is the Catalogue of 
Surveillance Systems (available at: http://www.nccor.org/css/index.html [January 27, 
2012]), which is an online resource of more than 80 health monitoring systems relevant to 
physical activity, diet, and obesity. These types of data resources are critical to efforts in 
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further understanding the quantitative effects of different risk factors and effective 
interventions across multiple levels that may result in beneficial changes.
To plan for the future, it is imperative to know where we are and from whence we have 
come. Thus, it is important to monitor and evaluate the prevalence of and trends in health 
behaviors and disease incidence. Quality, population-based risk factor and cancer 
surveillance data can be used to identify areas and populations with unhealthy behaviors and 
high cancer rates that could benefit from targeted, effective strategies and interventions to 
improve health behaviors and support healthy environments.
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Figure 1. 
The distribution of body mass index (BMI) is illustrated over time for adult (ages 20–74 
years) (A) men and (B) women by sex and survey year: United States, 1960 to 2008. Body 
mass index (BMI) is calculated as weight in kilograms divided by height in meters squared. 
BMI in the range 18.5–24.9 kg/m2 is considered healthy weight (dark green bars), BMI in 
the range 25–29.9 kg/m2 is considered overweight (medium green bars) and BMI ≥ 30 
kg/m2 is considered obese (light green bars). Prevalence was age-adjusted to the 2000 US 
standard population using five age groups: 20–34 years, 35–44 years, 45–54 years, 55–64 
years, and 65–74 years. Data are from the National Health and Nutrition Examination 
Survey except data for 1960–1962 which are from the National Health Examination Survey. 
Source: National Center for Health Statistics. Health, United States, 2010: With Special 
Feature on Death and Dying (Table 71). Hyattsville, MD. 2011.29
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Figure 2. 
These maps illustrate the proportion of US adults who were obese (body mass index [BMI] 
≥30 kg/m2) according to the Behavioral Risk Factor Surveillance (BRFSS) for the years 
1995, 2000, 2005, and 2010. BMI is calculated as weight in kilograms divided by height in 
meters squared. BMI is based on self-reported weight and height; prevalence is age-adjusted 
to the 2000 US standard population. Source: BRFSS public use file. (See Web Table 1).
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Figure 3. 
These maps illustrate the proportion of US adults who were physically inactive according to 
the Behavioral Risk Factor Surveillance System (BRFSS) for the years 2000, 2005, and 
2010. Physically inactive is defined as no moderate or vigorous-intensity aerobic activity for 
at least 10 minutes at a time; prevalence is age-adjusted to the 2000 US standard population. 
Source: BRFSS public use file. (See Web Table 1).
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Table 5
Current Prevalence of Overweight and Obesity Among US Children and Adolescents and Adults: National 
Health and Nutrition Examination Survey, 2007–2008a
Children and adolescents (ages 2–19 years)b Boys Girls
% Overweight % Obese % Overweight % Obese
All children and adolescents 14 18 15 16
By age, years
  2–5 11 10 11 11
  6–11 15 21 17 18
  12–19 16 19 17 17
By racial and ethnic group
  Non-Hispanic white 14 16 14 15
  Non-Hispanic black 16 17 16 23
  Hispanic 16 24 19 17
By education of household head
  College graduate NA 12 NA 8
  Some college NA 16 NA 15
  High school graduate NA 18 NA 20
  Less than high school NA 21 NA 20
Adults (aged ≥20 years)c Men Women
% Overweight % Obese % Overweight % Obese
All adults 40 32 29 36
By age, years
  20–39 36 28 26 34
  40–59 44 34 28 38
  ≥60 41 37 35 34
By racial and ethnic group
  Non-Hispanic white 41 32 28 33
  Non-Hispanic black 31 37 29 50
  Hispanic 45 34 33 43
By education
  College graduate NA 27 NA 23
  Some college NA 36 NA 38
  High school graduate NA 35 NA 40
  Less than high school NA 32 NA 42
Abbreviations: NA, not available.
aOverweight and obese were defined by body mass index (BMI), which is calculated as weight in kilograms divided by height in meters squared. 
Estimates are based on measured height and weight.
b
In children and adolescents, the definitions of overweight and obese are based on the 2000 Centers for Disease Control and Prevention (CDC) 
BMI-for-age-and-sex growth charts; BMI ranging from the ≥85th percentile to the <95th percentile is considered overweight, and BMI ≥95th 
percentile is considered obese. Sources: Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US 
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children and adolescents, 2007–2008. JAMA. 2010;303:242–24826; and Ogden CL, Lamb MM, Carroll MD, Flegal KM. Obesity and 
socioeconomic status in children and adolescents: United States, 2005–2008. NCHS Data Brief. 2010;(51):1–8.27
c
In adults, BMI in the range from 25.0 to 29.9 kg/m2 is considered overweight, and BMI ≥ 30 kg/m2 is considered obese. Sources: Flegal KM, 
Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–24125; and Ogden CL et 
al. Obesity and socioeconomic status in adults: United States, 2005–2008. NCHS Data Brief. 2010;(50):1–8.28
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Table 10
Relative Risk (RR) Associated with Excess Weight and Lack of Sufficient Physical Activity
Cancer Site and Type Summary RR From Comprehensive
Meta-Analysis (95% CI) per
Given Unit Increase in BMI
RR: Overweight
(BMI 25–29 kg/m2)
vs BMI <25 kg/m2a
RR: Obese
(BMI ≥30 
kg/m2)
vs BMI <25 
kg/m2a
Adenocarcinoma of esophagusb 1.11 (1.07–1.15) per 1 kg/m2 increase in BMI 1.55 2.10
Colorectalc 1.18 (1.14–1.21) per 5 kg/m2 increase in BMI 1.18 1.36
Pancreasb 1.14 (1.07–1.22) per 5 kg/m2 increase in BMI 1.14 1.28
Kidneyb 1.31 (1.24–1.39) per 5 kg/m2 increase in BMI 1.31 1.62
Postmenopausal breastd 1.05 (1.03–1.07) per 2 kg/m2 increase in BMI 1.13 1.25
Endometriale 1.60 (1.52–1.68) per 5 kg/m2 increase in BMI 1.60 2.20
Cancer Site and Type Summary RR From Comprehensive Meta-Analysis
(95% CI) for Level of Physical Activity
RR: Inactive vs
Most Activef
Colong 0.76 (0.72–0.81): Most active (recreational or occupational) vs least active 1.32
Postmenopausal breasth 0.75 (CI not given): Most active (recreational, occupational, or household) vs least 
active
1.33
Endometriali 0.73 (0.58–0.93): Highest activity (recreational) vs lowest activity 1.37
Abbreviations: BMI, body mass index; CI, confidence interval; RR, relative risk.
a
Published estimates were given as the risk associated with a specified unit change in BMI. Assuming a linear association between BMI and cancer 
risk, estimates were calculated for the risk associated with overweight and obese.
bSource: World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: 
A Global Perspective. Washington, DC: American Institute for Cancer Research; 2007.24
cSource: Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational 
studies. Obes Rev. 2010;11:19–30.37
dSource: World Cancer Research Fund/American Institute for Cancer Research. The Associations Between Food, Nutrition and Physical Activity 
and the Risk of Breast Cancer: WCRF/AICR Systematic Literature Review Continuous Update Report. Washington, DC: American Institute for 
Cancer Research; 2008.38
eSource: Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer 
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